About Ivabradine
            
            Class: | Antianginal agent, selective If channel inhibitor  
Use: | Treatment of chronic stable angina pectoris in patients with normal sinus rhythm who are unable to tolerate beta-blockers or for whom beta-blockers are contraindicated  
Adult dose: | Initial dose of 5 mg taken orally twice daily; may be increased to 7.5 mg twice daily based on heart rate and tolerability  
Pediatric dose: | Safety and efficacy not established in pediatric patients; not recommended for use in children  
Side eff
         
        
            
                
                
                    
                        Drug Class
                    
                    Antianginal agent, selective If channel inhibitor
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of chronic stable angina pectoris in patients with normal sinus rhythm who are unable to tolerate beta-blockers or for whom beta-blockers are contraindicated
                 
                
                
                    
                        Storage Requirements
                    
                    Store at room temperature (15°C to 30°C or 59°F to 86°F) in a tightly closed container, protected from moisture and light
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Les Laboratoires Servier Industrie, FRANCE
                    
                    
                    Package Size
                    56's (14's Blister x 4)
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 334.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Initial dose of 5 mg taken orally twice daily; may be increased to 7.5 mg twice daily based on heart rate and tolerability
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients; not recommended for use in children
                    
                 
                
                
                    
                        Side Effects
                    
                    Common side effects include bradycardia, hypertension, visual disturbances (phosphenes), dizziness, and headache
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Contraindicated in patients with severe hepatic impairment, sick sinus syndrome, pacemaker dependence, hypotension, and in combination with strong CYP3A4 inhibitors
         
        
        
            
                Important Warnings
            
            Risk of bradycardia; monitor heart rate regularly; caution in patients with a history of arrhythmias; may cause visual disturbances; not recommended in patients with acute coronary syndrome or heart failure
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.